GDRX GoodRx Holdings, Inc.
Healthcare$2.78+4.91%ClosedMarket Cap: $963.6M
As of 2026-05-26
Valuation
P/E (TTM)
24.66
PEG
1.06
P/B
1.45
P/S
1.17
EV/EBITDA
4.23
DCF Value
$4.72
FCF Yield
14.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.6%
Operating Margin
10.7%
Net Margin
2.6%
ROE
3.3%
ROA
1.0%
ROIC
3.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $194.0M | 78.4% | $19.5M | $1.2M | $— | — |
| Q4 null | $194.8M | 91.0% | $22.7M | $5.4M | $— | — |
| FY null | $796.9M | 92.8% | $87.5M | $30.4M | $— | — |
| Q3 null | $196.0M | 93.2% | $14.6M | $1.1M | $— | — |
| Q2 null | $203.1M | 83.7% | $27.7M | $12.8M | $— | — |
| Q1 null | $203.0M | 93.4% | $23.4M | $11.1M | $— | — |
| Q4 null | $198.6M | 93.9% | $18.2M | $6.7M | $— | — |
| FY null | $792.3M | 93.9% | $65.8M | $16.4M | $— | — |
| Q3 null | $195.3M | 94.0% | $20.4M | $12.3M | $— | — |
| Q2 null | $200.6M | 94.1% | $19.9M | $6.7M | $— | — |
| Q1 null | $197.9M | 93.7% | $7.4M | $-1.0M | $— | — |
| Q4 2023 | $196.6M | 92.3% | $-18.3M | $-25.9M | $-0.06 | — |